In Vivo Toxicology Market to Surpass USD 25.90 Billion by 2035; Rising Demand for Drug Safety Assessment and Expanding Biologics Pipeline Driving Market Growth – SNS Insider
Austin, United States, March 17, 2026 (GLOBE NEWSWIRE) -- In Vivo Toxicology Market Size & Growth Analysis:
According to SNS Insider, The In Vivo Toxicology Market size is estimated at USD 8.66 Billion in 2025 and is expected to reach USD 25.90 Billion by 2035, growing at a CAGR of 11.58% over 2026-2035. The growth of the global in vivo toxicology market is fueled by the increasing demand for a holistic approach to safety evaluation during the development of pharmaceutical and biotechnology products. The growth of drug discovery pipelines, research into biologics, and gene therapies, and the increasing regulatory needs are also boosting the growth of the in vivo toxicology market.
Market Size and Forecast:
Get a Sample Report of In Vivo Toxicology Market: https://www.snsinsider.com/sample-request/7528
The U.S. In Vivo Toxicology Market is estimated at USD 3.02 billion in 2025 and is expected to reach USD 9.14 billion by 2035, growing at a CAGR of 11.72% over 2026-2035. The largest market share is held by the U.S. market, driven by a well-established pharmaceutical research industry, advanced research facilities, and the presence of a large number of contract research organizations.
Rising Pharmaceutical and Biotechnology Research to Propel Market Expansion Globally
Increasing development pipelines of pharmaceuticals and biotechnology is fuelling the growth of the global in vivo toxicology market. Regulatory bodies require a systems approach to all for toxicology studies, as the safety, tolerability and adverse events associated with drugs must be evaluated before entering into clinical trial. Research on biologics, gene therapy, and advanced therapeutics is on the rise, and this is also a key factor accelerating in vivo toxicology market growth.
Major Players Listed in this Report:
Segmentation Analysis:
By Product
In 2025, the consumables segment captured the largest share of around 61.48% of total revenue due to continuous use of reagents, kits, and animal models in toxicology studies. The instruments segment is projected to grow steadily during the forecast period driven by advancements in laboratory technologies.
By Test Type
Acute toxicity testing held the largest market share of 29.66% in 2025 due to its importance in early-stage drug safety evaluation. Chronic toxicity testing is expected to grow at the fastest CAGR of 12.41% during the forecast period.
By Testing Facility
Outsourced testing facilities dominated the market with a share of approximately 63.18% in 2025, driven by increasing reliance on contract research organizations for specialized toxicology studies.
By Toxicity Endpoint
Systemic toxicity accounted for the largest share of 31.22% in 2025 due to its role in evaluating overall physiological impact of drug candidates. Developmental & reproductive toxicity (DART) is expected to grow at the fastest CAGR.
By End User
Pharmaceutical and biotechnology companies held the largest share of around 46.55% in 2025, while contract research organizations are projected to register the fastest growth during the forecast period.
Need Any Customization Research on In Vivo Toxicology Market, Enquire Now: https://www.snsinsider.com/enquiry/7528
In Vivo Toxicology Market Segmentation
By Product
By Test Type
By Testing Facility
By Toxicity Endpoint
By End User
Regional Insights:
North America held approximately 41.26% of global market revenue in 2025. The U.S. pharmaceutical and biotechnology ecosystem is the most productive drug development engine in the world by most measures, and FDA preclinical requirements set a high floor for the depth of animal safety data that IND applications must include.
Asia Pacific is the fastest-growing regional market at a CAGR of 12.94% through the forecast period. China leads WuXi AppTec and Pharmaron have built large-scale GLP-compliant toxicology facilities serving both domestic sponsors and Western companies reducing preclinical study costs through geographic diversification.
Developments:
Exclusive Sections of the Report (The USPs):
In Vivo Toxicology Market Report Scope
Purchase Single User PDF of In Vivo Toxicology Market Report (20% Discount): https://www.snsinsider.com/checkout/7528
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Market Overview
4. Statistical Insights & Trends Reporting
5. In Vivo Toxicology Market Segmental Analysis & Forecast, By Product
6. In Vivo Toxicology Market Segmental Analysis & Forecast, By Test Type
7. In Vivo Toxicology Market Segmental Analysis & Forecast, By Testing Facility
8. In Vivo Toxicology Market Segmental Analysis & Forecast, By Toxicity Endpoint
9. In Vivo Toxicology Market Segmental Analysis & Forecast, By End User
10. In Vivo Toxicology Market Segmental Analysis & Forecast, By Region
11. Competitive Landscape
12. Analyst Recommendations
13. Assumptions
14. Disclaimer
15. Appendix
Browse Other Reports
Preclinical CRO Market Report
Drug Discovery Market Report
Biologics Market Report
Clinical Trials Market Report
Pharmacovigilance Market Report
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.